Quarterly report · Q3
4320.TEDINET S100OUM4
Period2021-10-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.2bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥12.3bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.5bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥715m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥594m | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥727m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥909m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥620m | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥750m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥621m | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥362m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥633m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥315m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥410m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥379m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥10.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥9.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.6bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥5.5bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.1bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥24.13 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.78 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.34 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.1 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.51 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-10-01 → 2022-06-30 | ¥242m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-10-01 → 2022-06-30 | ¥242m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-10-01 → 2022-06-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥106m |
| jpcrp040300-q3r_E05233-000Medical Solution Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥9.9bn |
| jpcrp040300-q3r_E05233-000Medical Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥9.9bn |
| jpcrp040300-q3r_E05233-000Medical Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥812m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-06-30 | ¥10.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-06-30 | ¥10.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-06-30 | ¥821m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-10-01 → 2021-06-30 | ¥121m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-10-01 → 2021-06-30 | ¥121m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | ¥3m |
| jpcrp040300-q3r_E05233-000Medical Solution Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥8.4bn |
| jpcrp040300-q3r_E05233-000Medical Solution Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥8.4bn |
| jpcrp040300-q3r_E05233-000Medical Solution Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥597m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-06-30 | ¥8.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-06-30 | ¥8.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-06-30 | ¥590m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 339
| Item | Context | Value | Unit |
|---|---|---|---|
| Current portion of long term loans payable | Prior1YearInstant | 494878000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 604228000 | JPY |
| Income taxes payable | Prior1YearInstant | 281022000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 217206000 | JPY |
| Provision for bonuses | Prior1YearInstant | 238375000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 249077000 | JPY |
| Other cl | Prior1YearInstant | 636507000 | JPY |
| Other cl | CurrentQuarterInstant | 1012660000 | JPY |
| Current liabilities | Prior1YearInstant | 2861653000 | JPY |
| Current liabilities | CurrentQuarterInstant | 2824988000 | JPY |
| Bonds payable | Prior1YearInstant | 5000000 | JPY |
| Bonds payable | CurrentQuarterInstant | － | JPY |
| Long term loans payable | Prior1YearInstant | 841158000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 1335551000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 189782000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 189472000 | JPY |
| Other ncl | Prior1YearInstant | 82312000 | JPY |
| Other ncl | CurrentQuarterInstant | 221571000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1118252000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 1746595000 | JPY |
| Liabilities | Prior1YearInstant | 3979906000 | JPY |
| Liabilities | CurrentQuarterInstant | 4571583000 | JPY |
| Capital stock | Prior1YearInstant | 1175942000 | JPY |
| Capital stock | CurrentQuarterInstant | 1198552000 | JPY |
| Capital surplus | Prior1YearInstant | 1201794000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1224404000 | JPY |
| Retained earnings | Prior1YearInstant | 2763441000 | JPY |
| Retained earnings | CurrentQuarterInstant | 3066375000 | JPY |
| Treasury stock | Prior1YearInstant | -100410000 | JPY |
| Treasury stock | CurrentQuarterInstant | -100410000 | JPY |
| Shareholders equity | Prior1YearInstant | 5040768000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 5388921000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 31862000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 17486000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 31862000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 17486000 | JPY |
| Non controlling interests | Prior1YearInstant | 406541000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 409720000 | JPY |
| Net assets | Prior1YearInstant | 5479172000 | JPY |
| Net assets | CurrentQuarterInstant | 5816128000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 9459079000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 10387712000 | JPY |
| Net sales | Prior1YTDDuration | 8548467000 | JPY |
| Net sales | CurrentYTDDuration | 10184608000 | JPY |
| Cost of sales | Prior1YTDDuration | 6683855000 | JPY |
| Cost of sales | CurrentYTDDuration | 7931491000 | JPY |
| Gross profit | Prior1YTDDuration | 1864611000 | JPY |
| Gross profit | CurrentYTDDuration | 2253116000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1270984000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1538127000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |